Breath Therapeutics GmbH develops drug-aerosol therapeutics for treatment of Bronchiolitis Obliterans Syndrome (BOS)

Breath Therapeutics GmbH
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttp://breath-therapeutics.com
Founded2017
Disease Focus
Development Stage
STOCK CODENon Listed
AddressAubergenviller Allee 67a 64807 Dieburg, Rhein-Main FrankfurtGermany
Aubergenviller Allee 67a 64807 Dieburg, Rhein-Main
Frankfurt
Germany
Contact Number
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]